A series of Delta(2)-isoxazoline derivatives structurally related to Broxaterol 1 and Falintolol 3 has been prepared and evaluated for their binding affinity to beta(1)- and beta(2)-adrenergic receptors. Among the tested compounds only the 3-isopropenyl anti derivative 4d is as active as the reference compounds. An electron-releasing group, probably operating through a pi-pi interaction, in the 3-position of the isoxazoline nucleus greatly enhances the affinity of the compounds. Conversely, the closest analogs of Broxaterol (3-bromo Delta(2)-isoxazolines 4a and 5a) are at least one order of magnitude less active than the model compound 1. Throughout the series of derivatives the anti stereoisomers are invariably more active than their syn counterparts. (C) 1998 Elsevier Science Ltd. All rights reserved.

Synthesis of new Delta(2)-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists / P. Conti, C. Dallanoce, M. De Amici, C. De Micheli, K.N. Klotz. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - 6:4(1998), pp. 401-408.

Synthesis of new Delta(2)-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists

P. Conti
Primo
;
C. Dallanoce
Secondo
;
M. De Amici;C. De Micheli
Penultimo
;
1998

Abstract

A series of Delta(2)-isoxazoline derivatives structurally related to Broxaterol 1 and Falintolol 3 has been prepared and evaluated for their binding affinity to beta(1)- and beta(2)-adrenergic receptors. Among the tested compounds only the 3-isopropenyl anti derivative 4d is as active as the reference compounds. An electron-releasing group, probably operating through a pi-pi interaction, in the 3-position of the isoxazoline nucleus greatly enhances the affinity of the compounds. Conversely, the closest analogs of Broxaterol (3-bromo Delta(2)-isoxazolines 4a and 5a) are at least one order of magnitude less active than the model compound 1. Throughout the series of derivatives the anti stereoisomers are invariably more active than their syn counterparts. (C) 1998 Elsevier Science Ltd. All rights reserved.
synthesis; binding affinity; adrenergic antagonists; Broxaterol analogs; Falintolol analogs
Settore CHIM/08 - Chimica Farmaceutica
1998
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/183313
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 102
  • ???jsp.display-item.citation.isi??? 91
social impact